Sign in

NCT05830253Completed

Free-living Monitoring of Parkinson's Disease Using Smart Objects

Free-living Monitoring of Parkinson's Disease Using Smart Objects: Towards Digital Medicine

Source: ClinicalTrials.gov · Last updated 20 Feb 2025

Brief summary (registry, in English)

Parkinson's disease, one of the most common neurodegenerative diseases of the central nervous system, presents motor symptoms, including tremor, rigidity, bradykinesia, and postural instability. Assessments of patients with Parkinson's disease are typically performed using clinical scales, compiled by the healthcare staff or by the patient. Although commonly used in clinical practice, they have some limitations, including the low temporal resolution of the scales, the low granularity of the scores and the possible low inter- and intra-operator reliability. The recent development of digital technologies has led to the creation of IoT (Internet of Things) devices capable of providing quantitative indicators, potentially useful for an accurate differential diagnosis, as well as for monitoring the effects of therapeutic interventions. The peculiarity of these systems is the ability to provide indicators not only during periodic visits to the clinic, but also the ability to remotely monitor the patient's daily life activities. In this scenario, this study wants to test the hypothesis that the IoT devices like smart-ink pens and insoles are usable options for monitoring patients with Parkinson's disease.

Status (registry)
Completed
Study type
Observational
Enrollment
30 (actual)
First submitted
8 Mar 2023
Start date
8 Sept 2021
Primary completion date
31 Dec 2024
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
NCT number
NCT05830253

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 8 Sept 2021 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of major neurological, vascular, musculoskeletal disorders

Other illness

  • Unstable pharmacological treatment for Parkinson's Disease during the study

Who the study is looking for

  • Adult individuls
  • Cognitive impairments
  • Ability to independently sign the written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituti Clinici Scientifici Maugeri
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.